Cited by 693Bone Metabolism and DiseasesRheumatoid Arthritis Research and TherapiesOsteomyelitis and Bone Disorders Research

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Open access

Arai, Fumio, Miyamoto, Takeshi, Ohneda, Osamu, Inada, Tomohisa, Sudo, Tetsuo, Brasel, Kenneth, Miyata, Takashi, Anderson, Dirk M., Suda, Toshio·1999·The Journal of Experimental Medicine

DOI 10.1084/jem.190.12.1741PMC PMC2195707

Open this paper in CoChat — free account

Abstract

Osteoclasts are terminally differentiated cells derived from hematopoietic stem cells. However, how their precursor cells diverge from macrophagic lineages is not known. We have identified early and late stages of osteoclastogenesis, in which precursor cells sequentially express c-Fms followed by receptor activator of nuclear factor κB (RANK), and have demonstrated that RANK expression in early-stage of precursor cells (c-Fms+RANK−) was stimulated by macrophage colony-stimulating factor (M-CSF). Although M-CSF and RANKL (ligand) induced commitment of late-stage precursor cells (c-Fms+RANK+) into osteoclasts, even late-stage precursors have the potential to differentiate into macrophages without RANKL. Pretreatment of precursors with M-CSF and delayed addition of RANKL showed that timing of RANK expression and subsequent binding of RANKL are critical for osteoclastogenesis. Thus, the RANK–RANKL system determines the osteoclast differentiation of bipotential precursors in the default pathway of macrophagic differentiation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1084/jem.190.12.1741

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Self-citation
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Purification and Characterization of Mouse Hematopoietic Stem Cells
Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,908
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Self-citation
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Self-citation
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingPreprint
Lomaga, M. A., Yeh, W., Sarosi, I., Duncan, G. S., Furlonger, C. L., Ho, A. P., Morony, S., Capparelli, C., Van, G. Y., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,265

Flagged first, then by citations

Show all 54 references

1 of the 54 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Roodman, 1996, Advances in bone biologythe osteoclast, Endocr. Rev., 17, 308

Sorted by citations

Items 101–200 of 692

Gut microbiota-bone axis
Villa, C., Ward, W. E., & Comelli, E. M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2015.1010034 · Cited by 132
RANK Overexpression in Transgenic Mice with Mouse Mammary Tumor Virus Promoter-Controlled RANK Increases Proliferation and Impairs Alveolar Differentiation in the Mammary Epithelia and Disrupts Lumen Formation in Cultured Epithelial Acini
González‐Suárez, E., Branstetter, D. G., Armstrong, A. P., Dinh, H., Blumberg, H., & Dougall, W. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01298-06 · Cited by 128
Advances in osteoclast biology resulting from the study of osteopetrotic mutations
Segovia‐Silvestre, T., Neutzsky-Wulff, A. V., Sørensen, M. G., Christiansen, C., Bollerslev, J., Karsdal, M. A., & Henriksen, K. (2008) · Human Genetics · doi:10.1007/s00439-008-0583-8 · Cited by 128
Heme oxygenase 1 (HO‐1) regulates osteoclastogenesis and bone resorption
Zwerina, J., Tzima, S., Hayer, S., Redlich, K., Hoffmann, O., Hanslik‐Schnabel, B., Smolen, J. S., Kollias, G. A., & Schett, G. A. (2005) · The FASEB Journal · doi:10.1096/fj.05-4278fje · Cited by 130
Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways
Li, C., Yang, Z., Li, Z., Ma, Y., Zhang, L., Zheng, C., Qiu, W., Wu, X. G., Wang, X., Li, H., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.242 · Cited by 125
IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF-κB Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression
Park‐Min, K., Ji, J.-D., Antoniv, T. T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M. C., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804165 · Cited by 123
Vitamin D endocrine system and osteoclasts
Takahashi, N., Udagawa, N., & Suda, T. (2014) · BoneKEy Reports · doi:10.1038/bonekey.2013.229 · Cited by 129
Self-citation
Bone-turnover markers in fracture healing
Cox, G., Einhorn, T. A., Tzioupis, C. C., & Giannoudis, P. V. (2010) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.92b3.22787 · Cited by 120
Modulation of osteoclast formation
Quinn, J. M. W., & Gillespie, M. T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.076 · Cited by 121
Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells
Yagi, M., Miyamoto, T. K., Toyama, Y., & Suda, T. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-006-0697-9 · Cited by 121
Self-citation
Effect of Age on Regulation of Human Osteoclast Differentiation
Chung, P., Zhou, S., Eslami, B., Shen, L., LeBoff, M. S., & Glowacki, J. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24792 · Cited by 116
Regulation of bone homeostasis: signaling pathways and therapeutic targets
Wu, Z., Li, W., Jiang, K., Lin, Z., Qian, C., Wu, M., Xia, Y., Li, N., Zhang, H., Xiao, H.-X., et al. (2024) · MedComm · doi:10.1002/mco2.657 · Cited by 129
TLR2-dependent Modulation of Osteoclastogenesis by Porphyromonas gingivalis through Differential Induction of NFATc1 and NF-κB
Zhang, P., Liu, J., Xu, Q., Harber, G. J., Feng, X., Michalek, S. M., & Katz, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198085 · Cited by 116
Osteoimmunology: cytokines and the skeletal system
Lee, S., Kim, T. S., Choi, Y., & Lorenzo, J. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.7.495 · Cited by 117
Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways
Yuan, F., Xu, R., Jiang, D., He, X., Su, Q., Jin, C., & Li, X. (2015) · Bone · doi:10.1016/j.bone.2015.02.017 · Cited by 112
Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice, including accelerated weight gain, hyperactivity and anxiolytic-like behaviour
Rosin, J. M., Vora, S. R., & Kurrasch, D. M. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.07.023 · Cited by 113
An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand
Miyamoto, T. K., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M., & Suda, T. (2000) · Blood · doi:10.1182/blood.v96.13.4335 · Cited by 109
Self-citation
Osteoclast Precursor Interaction with Bone Matrix Induces Osteoclast Formation Directly by an Interleukin-1-mediated Autocrine Mechanism
Yao, Z., Xing, L., Qin, C., Schwarz, E. M., & Boyce, B. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706415200 · Cited by 111
The origins and roles of osteoclasts in bone development, homeostasis and repair
Yahara, Y., Nguyen, T., Ishikawa, K., Kamei, K., & Alman, B. A. (2022) · Development · doi:10.1242/dev.199908 · Cited by 111
Lineage-committed osteoclast precursors circulate in blood and settle down into bone
Muto, A., Mizoguchi, T., Udagawa, N., Ito, S., Kawahara, I., Abiko, Y., Arai, A., Harada, S., Kobayashi, Y., Nakamichi, Y., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.490 · Cited by 109
Molecular determinants for the polarization of macrophage and osteoclast
Yang, D., & Wan, Y. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00754-3 · Cited by 104
Cytokines regulating osteoclast formation and function
Lee, S., & Lorenzo, J. (2006) · Current Opinion in Rheumatology · doi:10.1097/01.bor.0000231911.42666.78 · Cited by 103
Activin A stimulates IκB‐α/NFκB and rank expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors
Sugatani, T., Alvarez, U., & Hruska, K. A. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10613 · Cited by 102
Flt3+ macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia
Delprat, C., Arnaud, S., Jurdic, P., Nataf, S., Grasset, M.-F., Soulas, C., Domenget, C., Destaing, O., Rivollier, A., Perret, M., et al. (2002) · BMC Immunology · doi:10.1186/1471-2172-3-15 · Cited by 101
MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation
Dou, C., Zhang, C., Kang, F., Yang, X., Jiang, H., Bai, Y., Xiang, J., Xu, J., & Dong, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.002 · Cited by 100
Lipid metabolism and rheumatoid arthritis
Lei, Q., Yang, J., Li, L., Zhao, N., Lu, C. C., Lü, A., & He, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1190607 · Cited by 102
HIV: Inflammation and Bone
Ofotokun, I., McIntosh, E. B., & Weitzmann, M. N. (2011) · Current HIV/AIDS Reports · doi:10.1007/s11904-011-0099-z · Cited by 99
Pathophysiological mechanisms of root resorption after dental trauma: a systematic scoping review
Galler, K. M., Grätz, E.-M., Widbiller, M., Buchalla, W., & Knüttel, H. (2021) · BMC Oral Health · doi:10.1186/s12903-021-01510-6 · Cited by 106
Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review
Nevius, E., Gomes, A. C., & Pereira, J. P. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8520-9 · Cited by 100
Immune regulation of bone loss by Th17 cells
Adamopoulos, I. E., & Bowman, E. P. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2502 · Cited by 101
Human T-Cell Leukemia Virus Type I Induces Adult T-Cell Leukemia: From Clinical Aspects to Molecular Mechanisms
Yasunaga, J., & Matsuoka, M. (2007) · Cancer Control · doi:10.1177/107327480701400206 · Cited by 98
Epigenetic and transcriptional regulation of osteoclast differentiation
Kurotaki, D., Yoshida, H., & Tamura, T. (2020) · Bone · doi:10.1016/j.bone.2020.115471 · Cited by 101
Activating transcription factor 4 regulates osteoclast differentiation in mice
Cao, H., Yu, S., Yao, Z., Galson, D. L., Jiang, Y., Zhang, X., Fan, J., Lu, B., Guan, Y., Luo, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42106 · Cited by 100
c- myc Is Required for Osteoclast Differentiation
Battaglino, R. A., Kim, D., Fu, J. Q., Vaage, B., Fu, X.-Y., & Stashenko, P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.763 · Cited by 97
PERK controls bone homeostasis through the regulation of osteoclast differentiation and function
Guo, J., Ren, R., Sun, K., Yao, X., Lin, J., Wang, G., Guo, Z., Xu, T., & Guo, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03046-z · Cited by 96
The origins and formation of bone-resorbing osteoclasts
Elson, A., Anuj, A., Barnea-Zohar, M., & Reuven, N. (2022) · Bone · doi:10.1016/j.bone.2022.116538 · Cited by 95
Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement
Roato, I., Grano, M., Brunetti, G., Colucci, S. C., Mussa, A., Bertetto, O., & Ferracini, R. (2004) · The FASEB Journal · doi:10.1096/fj.04-1823fje · Cited by 95
Hyaluronan–CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9
Spessotto, P., Rossi, F. M., Degan, M., Francia, R. D., Perris, R., Colombatti, A., & Gattei, V. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202120 · Cited by 95
MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner
Miyamoto, K., Ninomiya, K., Sonoda, K., Miyauchi, Y., Hoshi, H., Iwasaki, R., Miyamoto, H., Yoshida, S., Sato, Y., Morioka, H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.020 · Cited by 94
Self-citation
Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation
Lee, J., Kim, K., Kim, J. H., Jin, H. M., Choi, H. K., Lee, S., Kook, H. Y., Kim, K. K., Yokota, Y., Lee, S. Y., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2798 · Cited by 93
c-Fos plays an essential role in the up-regulation of RANK expression in osteoclast precursors within the bone microenvironment
Arai, A., Mizoguchi, T., Harada, S., Kobayashi, Y., Nakamichi, Y., Yasuda, H., Penninger, J. M., Yamada, K., Udagawa, N., & Takahashi, N. (2012) · Journal of Cell Science · doi:10.1242/jcs.099986 · Cited by 95
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh, K., Udagawa, N., Matsuzaki, K., Takami, M., Amano, H., Shinki, T., Ueno, Y., Takahashi, N., & Suda, T. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1766 · Cited by 90
Self-citation
Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells
Ma, Y., Qiao, X., Zeng, R., Cheng, R., Zhang, J., Luo, Y., Nie, Y., Hu, Y., Yang, Z., Zhang, J., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700983rr · Cited by 89
Modulation of osteoclast differentiation and bone resorption by Rho GTPases
Touaitahuata, H., Blangy, A., & Vives, V. (2014) · Small GTPases · doi:10.4161/sgtp.28119 · Cited by 93
Bone Metastasis Pain, from the Bench to the Bedside
Aielli, F., Ponzetti, M., & Rucci, N. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020280 · Cited by 92
Src inhibitors: drugs for the treatment of osteoporosis, cancer or both?
Šušva, M., Missbach, M., & Green, J. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01567-4 · Cited by 89
Bone Metastasis of Breast Cancer: Molecular Mechanisms and Therapeutic Strategies
Pang, L., Chen, G., Xu, J. Y., Jia, Y., Chai, J., Huang, R., Li, A., Ge, H., Yu, S., & Cheng, H. (2022) · Cancers · doi:10.3390/cancers14235727 · Cited by 93
The Polyphenol Fisetin Protects Bone by Repressing NF-κB and MKP-1-Dependent Signaling Pathways in Osteoclasts
Léotoing, L., Wauquier, F., Guicheux, J., Miot-Noirault, É., Wittrant, Y., & Coxam, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068388 · Cited by 89
Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice
Huh, J.-E., Shin, J. H., Jang, E., Park, S. J., Park, D. R., Ko, R., Seo, D.-H., Kim, H. S., Lee, S. H., Choi, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22511 · Cited by 88
The Molecular Mechanism of Vitamin E as a Bone-Protecting Agent: A Review on Current Evidence
Wong, S. K., Mohamad, N.-V., Ibrahim, N. ‘., Chin, K., Shuid, A. N., & Ima-Nirwana, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061453 · Cited by 87
Transforming Growth Factor-β Induces Expression of Receptor Activator of NF-κB Ligand in Vascular Endothelial Cells Derived from Bone
Ishida, A., Fujita, N., Kitazawa, R., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111093200 · Cited by 86
Osteoclast Activated FoxP3+ CD8+ T-Cells Suppress Bone Resorption in vitro
Buchwald, Z. S., Kiesel, J. R., DiPaolo, R. J., Pagadala, M. S., & Aurora, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038199 · Cited by 84
Celiac Disease and Pediatric Type 1 Diabetes: Diagnostic and Treatment Dilemmas
Sud, S., MARCON, M. A., Assor, E., Palmert, M. R., Daneman, D., & Mahmud, F. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/161285 · Cited by 85
Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism
Wu, Y., Yang, Y., Wang, L., Chen, Y., Han, X., Sun, L., Chen, H., & Chen, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1109296 · Cited by 85
Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells
Šućur, A., Jajić, Z., Artuković, M., Matijašević, M. I., Anić, B., Flegar, D., Markotić, A., Kelava, T., Ivčević, S., Kovačić, N., et al. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1337-6 · Cited by 82
Follicle-stimulating hormone promotes RANK expression on human monocytes
Cannon, J. G., Kraj, B., & Sloan, G. J. (2010) · Cytokine · doi:10.1016/j.cyto.2010.11.011 · Cited by 81
Transcriptional Activity of Nuclei in Multinucleated Osteoclasts and Its Modulation by Calcitonin
Boissy, P., Saltel, F., Baly, C., Jurdic, P., & Machuca‐Gayet, I. (2002) · Endocrinology · doi:10.1210/endo.143.5.8813 · Cited by 81
Gorham-Stout Syndrome: A Monocyte-Mediated Cytokine Propelled Disease
Colucci, S. C., Taraboletti, G., Primo, L., Viale, A., Roca, C., Valdembri, D., Geuna, M., Pagano, M., Grano, M., Pogrel, M. A., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051019 · Cited by 81
Activation of p38 mitogen‐activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor
Matsumoto, M., SUDO, T., Maruyama, M., Osada, H., & Tsujimoto, M. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02231-6 · Cited by 79
Self-citation
PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts
Chiţu, V., Nacu, V., Charles, J. F., Henne, W. M., McMahon, H. T., Nandi, S., Ketchum, H., Harris, R., Nakamura, M. C., & Stanley, E. R. (2012) · Blood · doi:10.1182/blood-2012-04-425595 · Cited by 78
Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes
Hie, M., Yamazaki, M., & Tsukamoto, I. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.025 · Cited by 77
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles
Granchi, D., Amato, I., Battistelli, L., Ciapetti, G., Pagani, S., Avnet, S., Baldini, N., & Giunti, A. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.07.045 · Cited by 77
The Possible Role of TGF-β-Induced Suppressors of Cytokine Signaling Expression in Osteoclast/Macrophage Lineage Commitment In Vitro
Fox, S. W., Haque, S. J., Lovibond, A. C., & Chambers, T. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3679 · Cited by 77
Vitamin D Hormone Inhibits Osteoclastogenesis In Vivo by Decreasing the Pool of Osteoclast Precursors in Bone Marrow
Shibata, T., Shiraishi, A., Sato, T., Masaki, T., Sasaki, A., Masuda, Y. M., Hishiya, A., Ishikura, N., Higashi, S., Uchida, Y., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.622 · Cited by 77
IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis
Tohmonda, T., Yoda, M., Iwawaki, T., Matsumoto, M., Nakamura, M., Mikoshiba, K., Toyama, Y., & Horiuchi, K. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76765 · Cited by 76
Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target
Amin, N., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2019.126417 · Cited by 77
Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts
Hoshino, A., Ueha, S., Hanada, S., Imai, T., Ito, M., Yamamoto, K., Matsushima, K., Yamaguchi, A., & Iimura, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.113910 · Cited by 81
Imatinib as a potential antiresorptive therapy for bone disease
Dewar, A. L., Farrugia, A. N., Condina, M. R., To, L. B., Hughes, T. P., Vernon-Roberts, B., & Zannettino, A. C. W. (2006) · Blood · doi:10.1182/blood-2005-09-3568 · Cited by 74
IL-27 Abrogates Receptor Activator of NF-κB Ligand-Mediated Osteoclastogenesis of Human Granulocyte-Macrophage Colony-Forming Unit Cells through STAT1-Dependent Inhibition of c-Fos
Furukawa, M., Takaishi, H., Takito, J., Yoda, M., Sakai, S., Hikata, T., Hakozaki, A., Uchikawa, S., Matsumoto, M., Chiba, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802091 · Cited by 75
Stem cells applications in bone and tooth repair and regeneration: New insights, tools, and hopes
Meguid, E. M. A., Ke, Y., Ji, J., & El-Hashash, A. H. K. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25940 · Cited by 74
Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis
Lee, Y., Ha, J., Kim, H. J., Kim, Y.-S., Chang, E., Song, W., & Kim, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042234 · Cited by 76
Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo
Zhu, L., Wei, H., Wu, Y. Q., Yang, S., Xiao, L., Zhang, J., & Peng, B. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.003 · Cited by 72
CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts
Cui, W., Cuartas, E., Ke, J., Zhang, Q., Einarsson, H. B., Sedgwick, J. D., Li, J., & Vignery, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702811104 · Cited by 72
Novel osteoclast signaling mechanisms
Shinohara, M., & Takayanagi, H. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0005-1 · Cited by 72
MKK3/6-p38 MAPK Signaling Is Required for IL-1 β and TNF- α -Induced RANKL Expression in Bone Marrow Stromal Cells
Rossa, C., Ehmann, K., Liu, M., Patil, C. S., & Kirkwood, K. L. (2006) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2006.26.719 · Cited by 71
A TRPC1 Protein-dependent Pathway Regulates Osteoclast Formation and Function
Ong, E., Nesin, V., Long, C. L., Bai, C.-X., Guz, J. L., Ivanov, I. P., Abramowitz, J., Birnbaumer, L., Humphrey, M. B., & Tsiokas, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.459826 · Cited by 72
Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone
Hie, M., & Tsukamoto, I. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.003 · Cited by 71
Absence of MCP‐1 leads to elevated bone mass via impaired actin ring formation
Sul, O., Ke, K., Kim, W.-K., Kim, S., Lee, S., Kim, H., Kim, S., Suh, J., & Choi, H. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22879 · Cited by 71
RANKL Regulates Fas Expression and Fas-Mediated Apoptosis in Osteoclasts
Wu, X., Pan, G., McKenna, M. A., Zayzafoon, M., Xiong, W., & McDonald, J. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041022 · Cited by 71
The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
B cells and osteoblast and osteoclast development
Horowitz, M. C., Bothwell, A. L. M., Hesslein, D. G. T., Pflugh, D. L., & Schatz, D. G. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00328.x · Cited by 70
CSF-1 Regulation of Osteoclastogenesis for Tooth Eruption
Wise, G. E., Yao, S., Odgren, P. R., & Pan, F. (2005) · Journal of Dental Research · doi:10.1177/154405910508400911 · Cited by 69
Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK
Hu, L., Lind, T., Sundqvist, A., Jacobson, A., & Melhus, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013305 · Cited by 68
Canonical and non-canonical pathways of osteoclast formation.
Knowles, H. J., & Athanasou, N. A. (2009) · PubMed · doi:10.14670/hh-24.337 · Cited by 67
Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice
Zhang, Z., Welte, T., Troiano, N. W., Maher, S. E., Fu, X.-Y., & Bothwell, A. L. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.019 · Cited by 67
Ae2 a,b ‐Deficient mice exhibit osteopetrosis of long bones but not of calvaria
Jansen, I. D. C., Mardones, P., Lecanda, F., de Vries, T. J., Recalde, S., Hoeben, K. A., Schoenmaker, T., Ravesloot, J., van Borren, M. M. G. J., van Eijden, T. M. G. J., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-122598 · Cited by 66
Role of interleukin‐7 in bone and T‐cell homeostasis
Lee, S., & Surh, C. D. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00339.x · Cited by 66
Bone effects of vitamin D – Discrepancies between in vivo and in vitro studies
Suda, T., Takahashi, F., & Takahashi, N. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.011 · Cited by 66
Self-citation
Pax5-Deficient Mice Exhibit Early Onset Osteopenia with Increased Osteoclast Progenitors
Horowitz, M. C., Xi, Y., Pflugh, D. L., Hesslein, D. G. T., Schatz, D. G., Lorenzo, J., & Bothwell, A. L. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6583 · Cited by 65
Foxp3+ Regulatory T Cells in Bone and Hematopoietic Homeostasis
Fischer, L., Herkner, C., Kitte, R., Dohnke, S., Riewaldt, J., Kretschmer, K., & Garbe, A. I. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00578 · Cited by 64
The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation
Chang, E.-J., Ha, J., Huang, H., Kim, H. J., Woo, J. H., Lee, Y., Lee, Z. H., Kim, J. H., & Kim, H. (2008) · Journal of Cell Science · doi:10.1242/jcs.028217 · Cited by 63
Osteoclast Culture and Resorption Assays
Bradley, E. W., & Oursler, M. J. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-104-8_2 · Cited by 63
IL-3 Acts Directly on Osteoclast Precursors and Irreversibly Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation by Diverting the Cells to Macrophage Lineage
Khapli, S. M., Mangashetti, L. S., Yogesha, S. D., & Wani, M. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.142 · Cited by 63
The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity
Miyamoto, T. (2006) · Modern Rheumatology · doi:10.1007/s10165-006-0524-0 · Cited by 62
Self-citation
Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
Hansen, M. S., Madsen, K., Price, M. L., Søe, K., Omata, Y., Zaiss, M. M., Gorvin, C. M., Frost, M., & Rauch, A. (2024) · Bone Research · doi:10.1038/s41413-023-00312-6 · Cited by 66
Amlexanox Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss
Zhang, Y., Guan, H., Li, J., Fang, Z., Chen, W., & Li, F. (2015) · Scientific Reports · doi:10.1038/srep13575 · Cited by 63
Methotrexate Chemotherapy Promotes Osteoclast Formation in the Long Bone of Rats via Increased Pro-Inflammatory Cytokines and Enhanced NF-κB Activation
King, T. J., Georgiou, K. R., Cool, J. C., Scherer, M. A., Ang, E. S. M., Foster, B. K., Xu, J., & Xian, C. J. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.037 · Cited by 63
Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1
Madel, M., Ibáñez, L., Ciucci, T., Halper, J., Rouleau, M., Boutin, A., Hue, C., Duroux-Richard, I., Apparailly, F., Garchon, H., et al. (2020) · eLife · doi:10.7554/elife.54493 · Cited by 62
Identification of the Common Origins of Osteoclasts, Macrophages, and Dendritic Cells in Human Hematopoiesis
Xiao, Y., Zijl, S., Wang, L., de Groot, D., van Tol, M. J., Lankester, A. C., & Borst, J. G. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.04.012 · Cited by 63
Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK
Hie, M., Iitsuka, N., Otsuka, T., Nakanishi, A., & Tsukamoto, I. (2011) · Bone · doi:10.1016/j.bone.2011.08.019 · Cited by 61

Authors: Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T.
Affiliations: Meikai University (JP)
Institute of Molecular Embryology and Genetics, Kumamoto University (JP)
Toray Industries, Inc. (Japan) (JP)
dDepartment of Molecular Biology, Immunex Corporation, Seattle, Washington 98101-2936
ORCID: Arai, Fumio
Miyamoto, Takeshi
Ohneda, Osamu
Miyata, Takashi
Anderson, Dirk M.
Suda, Toshio
Venue: The Journal of Experimental Medicine
Publisher: Rockefeller University Press
Published: 1999-12-20
Volume: 190
Issue: 12
Pages: 1741-1754
ISSN: 0022-1007 (ISSN-L)
1540-9538
DOI: 10.1084/jem.190.12.1741
PMC: PMC2195707
OpenAlex: W2132408993
Cited by: 693
References: 54
Citations by year: 2026: 6 · 2025: 16 · 2024: 20 · 2023: 33 · 2022: 33 · 2021: 32 · 2020: 42 · 2019: 38 · 2018: 31 · 2017: 31 · 2016: 30 · 2015: 40 · 2014: 34 · 2013: 31 · 2012: 38
FWCI: 4.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: cc-by-nc-sa
Locations: The Journal of Experimental Medicine (publishedVersion)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Keywords: osteoclastogenesis, osteoclast precursor cells, c-fms, RANK, RANKL, macrophage colony-stimulating factor, macrophage differentiation, lineage commitment, hematopoietic stem cells
MeSH terms: Animals, Carrier Proteins, Cell Differentiation, Hematopoietic Stem Cells, Ligands, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Osteoclasts, Macrophage Colony-Stimulating Factor, Receptor, Macrophage Colony-Stimulating Factor, Receptors, Tumor Necrosis Factor, Cell Lineage, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks